A Trial on the Opportunity and Treatment of Residual Deformity After Reduction in Developmental Dislocation of the Hip

NCT02163603 | Unknown

• 1 other identifier: GuangzhouWCMC
• Study Type: observational
• Target: 2
• Locations: 0 countries
• Sites: N/A

Brief Summary

Developmental dislocation of the hip is a common disease in children, and its incidence in China is about 9 ‰.The pathological changes of it is complex. The reluxation , subluxation and residual deformity and other complications are relatively common after treatment. The X-ray appears great acetabular index and wide medial gap , small central-edge angle. As there is no effective methods for treating such complications , investigators conducted this trial to find and prove optimal intervention time and treatment programs.

Conditions

Developmental Dislocation of the Hip; Congenital Dislocation of Hip; Residual Deformity; Reduction

Outcome Measures

Primary Outcomes (1)

• Early treatment can achieve good results in the residual deformity after reduction in developmental dislocation of the hip

  Acetabular index of all ages were measured ，and the acetabular index of patients getting early treatment (pelvis osteotomy ) is normal in all ages according to "The measurements of normal acetabular index and Sharp acetabular angle in Chinese hips" publised on Chinese Journal of Orthopaedics in 2010.

  3 years

Study Arms (1)

Pelvic osteotomy

Procedure: Pelvic osteotomy

Interventions

Pelvic osteotomy PROCEDURE

Pelvic osteotomy

Eligibility Criteria

• Age: 1 Year - 14 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)
• Sampling Method: Probability Sample

Study Population

The south of China

You may not qualify if:

• Age \>14 years
• Patients are complicated with mental, neurological disorders (such as hypoxic-ischemic encephalopathy, epilepsy and dementia) or significant barriers to growth.
• Patients are complicated with cerebral palsy, multiple joint contractures disease.
• Children are complicated with dysfunction of liver and kidney , blood disorders, immune deficiency disease and ECG abnormalities.
• Parents refused further treatment.

Sponsors & Collaborators

• Hongwen Xu: lead
• Tongji Hospital: collaborator
• Union Hospital, Tongji Medical College, Huazhong University of Science and Technology: collaborator
• Hunan Children's Hospital: collaborator
• Shenzhen Children's Hospital: collaborator
• Foshan Hospital of Traditional Chinese Medicine: collaborator
• Wuhan Women and Children's Medical Center: collaborator

MeSH Terms

Conditions

Hip Dislocation

Condition Hierarchy (Ancestors)

Joint Dislocations; Joint Diseases; Musculoskeletal Diseases; Wounds and Injuries; Hip Injuries

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Guangzhou Women and Children's Medical Center

Study Record Dates

• First Submitted: May 6, 2014
• First Posted: June 13, 2014
• Study Start: September 1, 2014
• Primary Completion: December 1, 2024
• Last Updated: March 21, 2016

Record last verified: 2016-03